Stryker

$239.59
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$4.81 (+2.05%) Today
$0.00 (0.00%) As of 6:00 PM EST after-hours

Why Robinhood?

You can buy or sell Stryker and other stocks, options, and ETFs commission-free!

About SYK

Stryker Corp. engages in providing medical technology products and services. It operates through the following segments: Orthopaedics, MedSurg and Neurotechnology and Spine. The Orthopaedics segment provides reconstructive and trauma implant systems. The Medsurg segment deals with surgical equipment and navigation systems, endoscopy, patient handling, and reprocessed medical devices. The Neurotechnology and Spine segment pertains to spinal implants and neurovascular products. The company was founded by Homer H. Stryker in 1941 and is headquartered in Kalamazoo, MI. The listed name for SYK is Stryker Corporation.

CEO
Kevin A. Lobo
Employees
40,000
Headquarters
Kalamazoo, Michigan
Founded
1941
Market Cap
90.04B
Price-Earnings Ratio
50.84
Dividend Yield
0.98
Average Volume
1.19M
High Today
$239.45
Low Today
$234.41
Open Price
$234.50
Volume
834.37K
52 Week High
$242.51
52 Week Low
$124.54

Collections

SYK News

MarketWatchDec 2

Stryker raises dividend by 9.6%

Stryker Corp. SYK, +1.41% said late Wednesday that its board of directors has declared a quarterly dividend of 63 cents a share, payable Jan. 29 to shareholders

SYK Earnings

$0.00
$0.83
$1.66
$2.49
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Jan 26, After Hours

You May Also Like